PRO MEDICUS LIMITED — Earnings Release 2010

Aug 25, 2010

==> picture [161 x 35] intentionally omitted <==

Pro Medicus Limited 450 Swan Street Richmond Victoria 3121 Australia T +61 3 9429 8800 F +61 3 9429 9455 promedicus.com

Company Announcement

- Pro Medicus Full Year Results

Thursday 26 August 2010

• Net profit of $3.92 million, down 22% in line with guidance

• Second-half profit higher than first half

• Final dividend of 2 cents per share declared

• Visage acquisition performed to expectations, sets basis for company growth

• Strong balance sheet with cash reserves of $3.79 million

• Company remains debt-free

Leading e-health company Pro Medicus Limited [ASX: PME] today announced net profit for the 2009-10 year of $3.92 million, 21.9% lower than for the previous year. Profit was struck on revenue of $19.46 million, up 24.6%.

The company announced a total dividend return to shareholders of 2.0 cents per share fully franked.

During the year Pro Medicus consolidated its acquisition of Visage Imaging and launched new and exciting products.

Chief Executive Officer David Chambers said: “We are pleased to deliver a full-year result in line with our guidance and above the analyst consensus earnings forecast. Despite the general improvement in the economic climate, the aftermath of the Global Financial Crisis has seen healthcare spending remain subdued. In particular, spending in the US on healthcare has only marginally improved. In spite of this we grew consolidated revenue. Net profit in the second half was more than double that in the first half. However investments in research and development, coupled with high transitional operating costs, meant that the full-year profit was down by comparison with the prior year.”

Pro Medicus Limited ABN 25 006 194 752

==> picture [161 x 35] intentionally omitted <==

Pro Medicus Limited 450 Swan Street Richmond Victoria 3121 Australia T +61 3 9429 8800 F +61 3 9429 9455 promedicus.com

“Pro Medicus’ investment in research and development has resulted in the release of a new product category in the market, the Visage 7 Universal Viewer. This unique application combines 2-D and 3-D image review technology enabling primary interpretation ranging from plain film to cardiac computed tomography (CT), as well as state-of-the-art 3-D and 4-D (moving image) post-processing. Thin client technology means that there is no need to move and duplicate large sets of image data, and images can be seen on either PC or Macintosh hardware. Complementing this is Pro Medicus’ next generation Radiology Information System (RIS) technology platform, to manage the patient workflow, which is due for release in the current year”.

Mr Chambers said that three key sales in Australia in the second half of the year validate Pro Medicus’ investment in Visage Imaging technology, providing a strong basis for prospects for both new sales and up-selling to local and overseas clients – both imaging centres and hospitals.

“The level of interest in our new products and the traction we are getting with our complete solution – incorporating RIS, PACS and 3-D advanced visualization products – gives us confidence for future growth, and endorses our strategic acquisition of, and further investment in, Visage Imaging. Locally our new-generation RIS platform – which is nearing completion – will be a quantum improvement over anything currently in the market.”

Mr Chambers said the company is confident that, dependant only on speed of take up, it has strong growth prospects with revenue growth in particular slated for both European and North American operations in the current year. “We expect gradual and sustained revenue and profit growth as we develop our presence in these markets. Already nearly half our income derives from overseas (28.5% from Europe and 19.8% from North America), which sets a solid foundation for future overseas growth.”

During the year Pro Medicus made several organizational changes in the US market, including widespread cost savings, installing a new General Manager, and adopting a more efficient sales model. The company expects its US operations to be profitable in 2010-2011.

Pro Medicus’ balance sheet at year-end remained strong, with no debt and cash of $3.79 million, down from $5.56 million as at June 2009. This reduction is largely a result of the ongoing investment in Visage Imaging and investment in local research and

Pro Medicus Limited ABN 25 006 194 752

==> picture [161 x 35] intentionally omitted <==

Pro Medicus Limited 450 Swan Street Richmond Victoria 3121 Australia T +61 3 9429 8800 F +61 3 9429 9455 promedicus.com

development. The cash balance leaves sufficient reserves to fund anticipated growth of the business from internal sources.

For further information:

Mr David Chambers Chief Executive Officer Pro Medicus Limited Ph: +613 94298800

Richard Allen Oxygen Financial PR Ph: +613 9915 6341

About Pro Medicus Limited: Pro Medicus Limited [ASX: PME] is Australia’s leading medical IT and e-health provider. Founded in 1983, the company provides a full range of integrated software products and services to individual, corporate and public health providers. More than 26,000 doctors are now connected to the company’s e-health service, promedicus.net, with the number of transactions across the network between general practitioners and specialists growing accordingly. A key growth area for the company is the adoption of its digital technology by radiology providers as they move away from analogue systems. An increasing number of Australian practices are taking up Pro Medicus’ digital technology and the company is now also making substantial inroads into the North American market. In late 2004, the company signed a watershed three-year $10 million deal with Agfa North America to exclusively license the Pro Medicus Practice Management and digital radiology software products for the large and rapidly growing private imaging centre market in the US and Canada. It subsequently announced a $2.6 million contract with a large Canadian radiology group which was completed in 2005. In 2007 and 2008 Pro Medicus achieved the predicted growth in the take up of its digital integration in the Australian private market, steady growth in its e-health offering, as well as recording ongoing growth in its export sales. In late January 2009 the company announced the purchase of Visage Imaging, a leader in advanced 3D visualization technology based in Carlsbad, California.

www.promedicus.com.au

Pro Medicus Limited ABN 25 006 194 752